
Efthymios (Timos) Ziogos
@tziogos
PGY-1 @OslerResidency @OslerPSP | Former Post-Doctoral Research Fellow @hopkinsheart
ID: 1188050491110035457
26-10-2019 11:11:40
71 Tweet
155 Followers
330 Following

🔥off the press #ESCCongress2024 intraindividual variability in Lp(a) presented by 🌟fellow Tarek Harb and simultaneous publication in EHJOpen Editor-in-Chief ‼️Maciej Banach Johns Hopkins Cardiology American University of Beirut Johns Hopkins Ciccarone Center The Osler Medical Residency


👉🏻Our study suggests repeat Lp(a) tests 🧪could be crucial for those in the #society_eas intermediate risk group. 53% could be reclassified with a second test. Time to rethink cardiovascular risk assessment. European Atherosclerosis Society EHJOpen Editor-in-Chief American Heart Association American College of Cardiology Tarek Harb

Happy 34th 🎂 to the Hopkins Johns Hopkins Ciccarone Center for Prevention of 🫀disease. We celebrated 4 recent promotions to Professor, 4 to Assoc. Prof, a new Fellowship jefe, 2 APD’s, a R21 & R35, 3 K awards, the new Pres of SVM, Wenger & Vogel awards, 2 R01s, the AHA-MD Pres 🎤 🙌


Association of Prepregnancy Cardiometabolic Health With Hypertensive Disorders of Pregnancy Among Historically Underrepresented Groups in the United States | Journal of the American Heart Association ahajournals.org/doi/full/10.11… Anum Minhas Yaa Adoma Kwapong, MD, MPH

Lipoprotein(a) Is Elevated and Inversely Related to Coronary Endothelial Function in People With HIV | Journal of the American Heart Association ahajournals.org/doi/full/10.11… Thorsten Leucker Yaa Adoma Kwapong, MD, MPH Anum Minhas

Huge congratulations to Thorsten Leucker and Wendy Post on earning the Frederick L. Brancati & David M. Levine Excellence in Mentoring Awards from Johns Hopkins Medicine ! 🎉 Your tireless support, guidance, and inspiration make all the difference. We're lucky to have mentors like you!


Excited to share our recent study on LA reverse remodeling in pts on LVAD support Circ: Heart Failure !! Key findings: - LA structure & function improve early & assoc w/ LV changes - Assoc w/ ⬇️ all-cause mortality & restoration to NSR - Implications for pts w/ earlier stage HF and AFib

Evolocumab given within 24 hr of admission for STEMI or NSTEMI significantly reduced myocardial inflammation at 30 days vs placebo. Could PCSK9i become standard therapy for acute MI? Congrats Efthymios (Timos) Ziogos The Osler Medical Residency Johns Hopkins Cardiology

Congratulations Efthymios (Timos) Ziogos Thorsten Leucker on important clinical trial on role of PCSK9i in acute MI!


We are proud to recognize Dr. Frank and Dr. Aronis as our Teachers of the Year! They generously give their time, energy, and expertise to our fellows - always going the extra mile to educate and support them. We are grateful for you both! Rachel Frank Konstantinos N. Aronis, MD PhD


Honored to see our work featured alongside this thoughtful editorial by Dr. Nicola Ferri in JACC: Basic to Translational Science! jacc.org/doi/10.1016/j.… Thorsten Leucker Tarek Harb